Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$430M |
| 3 |
Verizon
VZ
|
+$390M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Broadcom
AVGO
|
+$212M |
Top Sells
| 1 |
iShares MBS ETF
MBB
|
+$560M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$537M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$144M |
| 4 |
Oracle
ORCL
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| 1 | Technology | 20.19% |
| 2 | Financials | 13.06% |
| 3 | Healthcare | 12.04% |
| 4 | Consumer Discretionary | 10.99% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Altimmune
ALT
$321M
| $2.09M | ﹤0.01% |
212,550
+76,056
| +56% | +$749K |
|
|
TCS
2702
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $2.09M | ﹤0.01% |
10,695
-3,069
| -22% | -$600K |
|
|
VIA
2703
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $2.09M | ﹤0.01% |
36,811
-12,384
| -25% | -$702K |
|
2704
Globant
GLOB
$2.47B
| $2.08M | ﹤0.01% |
9,492
+3,333
| +54% | +$731K |
|
2705
Prelude Therapeutics
PRLD
$64M
| $2.08M | ﹤0.01% |
72,623
-2,045
| -3% | -$58.6K |
|
2706
RPC Inc
RES
$986M
| $2.07M | ﹤0.01% |
418,402
+17,410
| +4% | +$86.2K |
|
|
PRTK
2707
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $2.07M | ﹤0.01% |
302,670
+28,130
| +10% | +$192K |
|
|
GTYH
2708
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $2.04M | ﹤0.01% |
287,444
-14,621
| -5% | -$104K |
|
2709
Atlanta Braves Holdings Series A
BATRA
$2.86B
| $2.02M | ﹤0.01% |
71,531
+1,327
| +2% | +$37.5K |
|
|
TRIL
2710
DELISTED
Trillium Therapeutics Inc.
TRIL
| $2.01M | ﹤0.01% |
+207,353
| New | +$2.01M |
|
2711
Korro Bio
KRRO
$289M
| $2.01M | ﹤0.01% |
4,036
+61
| +2% | +$30.4K |
|
2712
Vera Bradley
VRA
$61.5M
| $2.01M | ﹤0.01% |
162,129
+18,071
| +13% | +$224K |
|
2713
Lifecore Biomedical
LFCR
$281M
| $2M | ﹤0.01% |
177,895
+5,057
| +3% | +$56.9K |
|
2714
Carisma Therapeutics
CARM
$15.6M
| $1.99M | ﹤0.01% |
21,519
+18,701
| +664% | +$1.73M |
|
2715
Peoples Financial Services
PFIS
$525M
| $1.98M | ﹤0.01% |
46,424
+1,509
| +3% | +$64.3K |
|
2716
Preformed Line Products
PLPC
$979M
| $1.98M | ﹤0.01% |
26,615
+5,396
| +25% | +$400K |
|
2717
Cognyte Software
CGNT
$622M
| $1.97M | ﹤0.01% |
80,557
-130,171
| -62% | -$3.19M |
|
2718
Advent Technologies
ADN
$7.98M
| $1.97M | ﹤0.01% |
6,816
+1,358
| +25% | +$393K |
|
2719
McEwen Inc.
MUX
$748M
| $1.97M | ﹤0.01% |
142,395
+18,717
| +15% | +$258K |
|
|
SCPL
2720
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $1.96M | ﹤0.01% |
115,770
+9,512
| +9% | +$161K |
|
2721
Byrna Technologies
BYRN
$453M
| $1.96M | ﹤0.01% |
+86,284
| New | +$1.96M |
|
2722
SIGA Technologies
SIGA
$639M
| $1.96M | ﹤0.01% |
311,659
-9,245
| -3% | -$58.1K |
|
2723
Sutro Biopharma
STRO
$74.3M
| $1.93M | ﹤0.01% |
103,998
+22,600
| +28% | +$420K |
|
2724
Park Aerospace
PKE
$372M
| $1.93M | ﹤0.01% |
129,389
+3,481
| +3% | +$51.9K |
|
2725
United States Lime & Minerals
USLM
$3.63B
| $1.93M | ﹤0.01% |
69,215
+300
| +0.4% | +$8.35K |
|